Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B

ObjectiveTo investigate the efficacy and safety of umbilical cord blood (UCB)-derived or autologous cytokine-induced killer (CIK) cells combined with interferon therapy in patients with chronic hepatitis B (CHB). MethodsThirty CHB patients hospitalized in the Department of Infectious Diseases from O...

Full description

Bibliographic Details
Main Author: LIU Bo
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2014-09-01
Series:Linchuang Gandanbing Zazhi
Subjects:
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=6003&ClassID=86133151